Cytokinetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	122.52	94.86	113.02	65.58	112.67
Short-Term Investments	759.7	981.16	501.8	717	358.97
Cash & Short-Term Investments	882.22	1,076	614.82	782.58	471.64
Cash Growth	-18.01%	75.01%	-21.44%	65.93%	1.63%
Accounts Receivable	17.76	16.65	1.28	0.15	51.82
Other Current Assets	16.99	15.28	11.94	12.46	12.22
Total Current Assets	916.98	1,108	628.05	795.19	535.67
Net Property, Plant & Equipment	155.17	140.97	147.74	163.19	146.41
Long-Term Investments	335.05	145.06	40.53	46.71	152.05
Other Long-Term Assets	17.34	7.71	8	9.69	7.19
Total Assets	1,425	1,402	824.32	1,015	841.32
Accounts Payable	22.34	20.37	21.51	25.61	21.09
Accrued Expenses	83.28	55.32	42.64	44.1	34.37
Current Portion of Long-Term Debt	41.18	11.52	10.08	0.96	-
Current Portion of Leases	19.11	18.98	17.89	12.83	14.86
Unearned Revenue	1.61	52.37	-	-	-
Other Current Liabilities	34.93	21.11	10.56	1.12	1.54
Total Current Liabilities	202.45	179.67	102.68	84.62	71.86
Long-Term Debt	1,116	645.6	607.37	609.62	142.84
Long-Term Leases	107.97	112.58	120.43	126.9	112.23
Other Long-Term Liabilities	657.76	599.19	380.16	301.55	270.53
Total Long-Term Liabilities	1,882	1,357	1,108	1,038	525.6
Total Liabilities	2,084	1,537	1,211	1,123	597.46
Common Stock	0.12	0.12	0.1	0.09	0.08
Additional Paid-in Capital	2,826	2,564	1,726	1,482	1,452
Accumulated Other Comprehensive Income	0.63	2.4	-0.01	-3.59	-0.87
Retained Earnings	-3,487	-2,702	-2,112	-1,586	-1,208
Shareholders' Equity	-659.63	-135.37	-386.32	-107.9	243.86
Total Liabilities & Equity	1,425	1,402	824.32	1,015	841.32
Total Debt	1,284	788.68	755.77	750.3	269.93
Net Cash (Debt)	-402.02	287.34	-140.95	32.28	201.71
Net Cash Growth	-	-	-	-84.00%	-37.96%
Net Cash Per Share	-3.35	2.57	-1.46	0.36	2.62
Book Value	-659.63	-135.37	-386.32	-107.9	243.86
Book Value Per Share	-5.49	-1.21	-4.00	-1.20	3.17
Tangible Book Value	-659.63	-135.37	-386.32	-107.9	243.86
Tangible Book Value Per Share	-5.49	-1.21	-4.00	-1.20	3.17

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q